Rising Pharmaceuticals recalls 2.5 mg chewable methylphenidate tablets due to size variation in some tablets. This may affect safety and requires verification of product details.
Failed Tablet Specifications: Recall of this drug product was voluntarily initiated by the manufacturer due to a market complaint, which stated that a tablet in the sealed bottle was twice larger in size when compared to the remaining tablets. This complaint is second of its kind.
Take action
Contact the company
📍Recalling firmRISING PHARMACEUTICALS2 Tower Center Blvd · East Brunswick, NJ 08816-1100
“Rising Pharmaceuticals Methylphenidate Tablets Recall: Size Variation Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35234-rising-pharmaceuticals-methylphenidate-tablets-recall-size-variation-risk. Based on FDA recall #D-0573-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0573-2022%22&limit=1).
Rising Pharmaceuticals voluntarily recalled Methylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottles due to failed tablet specifications, according to the FDA on Feb. 7, 2022. The recall was initiated after a complaint reported a tablet twice the normal size.
The recall addresses failed tablet specifications where a tablet was found to be twice larger than the remaining tablets in the sealed bottle. This complaint marks the second instance of this specific issue.
Context
GovInfoNow's records show Rising Pharmaceuticals has two other recalls on record since Sept. 2, 2021, including a Feb. 15, 2023 recall for Warfarin Tablets due to impurities risk and a Sept. 2, 2021 recall for Meclizine Tablets involving incorrect instructions. Other recent recalls of similar products include Major Pharmaceuticals Levothyroxine Tablets Recall (July 13, 2026), Alvogen Thyro-Tabs 150mcg Tablets Recall (Dec. 31, 2025), and Winder Morphine Sulfate Oral Solution Recall (Nov. 26, 2025).
How to tell if you have this one
Check for the product name 'Methylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottle' with the lot number 25910009 and expiration date 01/2023. The product is manufactured by Rising Pharmaceuticals in Saddle Brook, NJ.
Brand
Rising Pharmaceuticals
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Verify the product's lot number (25910009) and expiration date (01/2023) to confirm if it is recalled.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 23 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0573-2022 (February 7, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0573-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.